Delivery Order SPE2DB22D3301-SPE2DB26FX3YZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,216.96 to supply Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,197.63 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, valued at $2,252.20 under a firm fixed-price contract structure. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a $2,259.24 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $4,938.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania, supporting federal medical...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.81 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of August 28, 2025. This non-set-aside, competitively awarded contract reflects firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion through December 2026. The place of performance is located at...
- The Defense Logistics Agency awarded a $1,519.93 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3YZDelivery Order
The Defense Logistics Agency awarded a $2,633.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of October 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical prime vendor contract running through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. AmerisourceBergen Drug Corp serves as a critical pharmaceutical supplier to the Defense Logistics Agency's Medical Supply Chain, delivering a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order for Valtoco, an emergency seizure treatment, reflects the company's ongoing role in supplying specialized pharmaceutical products through the DLA's global pharmaceutical support vehicle. The contract award demonstrates AmerisourceBergen's continued capability to compete for and fulfill federal medical procurement requirements supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 10/28/25 |